These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

290 related articles for article (PubMed ID: 36188218)

  • 21. Both IDO1 and TDO contribute to the malignancy of gliomas via the Kyn-AhR-AQP4 signaling pathway.
    Du L; Xing Z; Tao B; Li T; Yang D; Li W; Zheng Y; Kuang C; Yang Q
    Signal Transduct Target Ther; 2020 Feb; 5(1):10. PubMed ID: 32296044
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Discovery and structure-activity relationship studies of 1-aryl-1H-naphtho[2,3-d][1,2,3]triazole-4,9-dione derivatives as potent dual inhibitors of indoleamine 2,3-dioxygenase 1 (IDO1) and trytophan 2,3-dioxygenase (TDO).
    Pan S; Zhou Y; Wang Q; Wang Y; Tian C; Wang T; Huang L; Nan J; Li L; Yang S
    Eur J Med Chem; 2020 Dec; 207():112703. PubMed ID: 32871341
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Tryptophan-catabolizing enzymes - party of three.
    Ball HJ; Jusof FF; Bakmiwewa SM; Hunt NH; Yuasa HJ
    Front Immunol; 2014; 5():485. PubMed ID: 25346733
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Synthesis of novel tryptanthrin derivatives as dual inhibitors of indoleamine 2,3-dioxygenase 1 and tryptophan 2,3-dioxygenase.
    Li Y; Zhang S; Wang R; Cui M; Liu W; Yang Q; Kuang C
    Bioorg Med Chem Lett; 2020 Jun; 30(11):127159. PubMed ID: 32247733
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Unveiling the Role of Tryptophan 2,3-Dioxygenase in the Angiogenic Process.
    Cecchi M; Anceschi C; Silvano A; Coniglio ML; Chinnici A; Magnelli L; Lapucci A; Laurenzana A; Parenti A
    Pharmaceuticals (Basel); 2024 Apr; 17(5):. PubMed ID: 38794128
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Indoleamine and tryptophan 2,3-dioxygenases as important future therapeutic targets.
    Dolšak A; Gobec S; Sova M
    Pharmacol Ther; 2021 May; 221():107746. PubMed ID: 33212094
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Tryptophan-2,3-Dioxygenase (TDO) deficiency is associated with subclinical neuroprotection in a mouse model of multiple sclerosis.
    Lanz TV; Williams SK; Stojic A; Iwantscheff S; Sonner JK; Grabitz C; Becker S; Böhler LI; Mohapatra SR; Sahm F; Küblbeck G; Nakamura T; Funakoshi H; Opitz CA; Wick W; Diem R; Platten M
    Sci Rep; 2017 Jan; 7():41271. PubMed ID: 28117398
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Substrate stereo-specificity in tryptophan dioxygenase and indoleamine 2,3-dioxygenase.
    Capece L; Arrar M; Roitberg AE; Yeh SR; Marti MA; Estrin DA
    Proteins; 2010 Nov; 78(14):2961-72. PubMed ID: 20715188
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Suppression of TDO-mediated tryptophan catabolism in glioblastoma cells by a steroid-responsive FKBP52-dependent pathway.
    Ott M; Litzenburger UM; Rauschenbach KJ; Bunse L; Ochs K; Sahm F; Pusch S; Opitz CA; Blaes J; von Deimling A; Wick W; Platten M
    Glia; 2015 Jan; 63(1):78-90. PubMed ID: 25132599
    [TBL] [Abstract][Full Text] [Related]  

  • 30.
    Yang D; Zhang S; Fang X; Guo L; Hu N; Guo Z; Li X; Yang S; He JC; Kuang C; Yang Q
    J Med Chem; 2019 Oct; 62(20):9161-9174. PubMed ID: 31580660
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Indoleamine 2,3-Dioxygenase 1: A Promising Therapeutic Target in Malignant Tumor.
    Song X; Si Q; Qi R; Liu W; Li M; Guo M; Wei L; Yao Z
    Front Immunol; 2021; 12():800630. PubMed ID: 35003126
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A narrative review of the roles of indoleamine 2,3-dioxygenase and tryptophan-2,3-dioxygenase in liver diseases.
    Zhou Q; Shi Y; Chen C; Wu F; Chen Z
    Ann Transl Med; 2021 Jan; 9(2):174. PubMed ID: 33569476
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Indoleamine 2,3-dioxygenase 2 (IDO2) and the kynurenine pathway: characteristics and potential roles in health and disease.
    Fatokun AA; Hunt NH; Ball HJ
    Amino Acids; 2013 Dec; 45(6):1319-29. PubMed ID: 24105077
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Tryptophan-2,3-dioxygenase is regulated by prostaglandin E2 in malignant glioma via a positive signaling loop involving prostaglandin E receptor-4.
    Ochs K; Ott M; Rauschenbach KJ; Deumelandt K; Sahm F; Opitz CA; von Deimling A; Wick W; Platten M
    J Neurochem; 2016 Mar; 136(6):1142-1154. PubMed ID: 26708701
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Efficient tryptophan-catabolizing activity is consistently conserved through evolution of TDO enzymes, but not IDO enzymes.
    Yuasa HJ; Ball HJ
    J Exp Zool B Mol Dev Evol; 2015 Mar; 324(2):128-40. PubMed ID: 25702628
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The potential of targeting indoleamine 2,3-dioxygenase for cancer treatment.
    Gostner JM; Becker K; Überall F; Fuchs D
    Expert Opin Ther Targets; 2015 May; 19(5):605-15. PubMed ID: 25684107
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Delaying aging and the aging-associated decline in protein homeostasis by inhibition of tryptophan degradation.
    van der Goot AT; Zhu W; Vázquez-Manrique RP; Seinstra RI; Dettmer K; Michels H; Farina F; Krijnen J; Melki R; Buijsman RC; Ruiz Silva M; Thijssen KL; Kema IP; Neri C; Oefner PJ; Nollen EA
    Proc Natl Acad Sci U S A; 2012 Sep; 109(37):14912-7. PubMed ID: 22927396
    [TBL] [Abstract][Full Text] [Related]  

  • 38. High-throughput fluorescence-based screening assays for tryptophan-catabolizing enzymes.
    Seegers N; van Doornmalen AM; Uitdehaag JC; de Man J; Buijsman RC; Zaman GJ
    J Biomol Screen; 2014 Oct; 19(9):1266-74. PubMed ID: 24870017
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Investigation of the Tissue Distribution and Physiological Roles of Indoleamine 2,3-Dioxygenase-2.
    Jusof FF; Bakmiwewa SM; Weiser S; Too LK; Metz R; Prendergast GC; Fraser ST; Hunt NH; Ball HJ
    Int J Tryptophan Res; 2017; 10():1178646917735098. PubMed ID: 29051706
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Tryptophan 2,3-dioxygenase, a novel therapeutic target for Parkinson's disease.
    Boros FA; Vécsei L
    Expert Opin Ther Targets; 2021 Oct; 25(10):877-888. PubMed ID: 34720020
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.